ASX:EVEFood, Beverage & TobaccoPackaged Foods & Meats
EVE HEALTH GROUP ORD
$0.019
Day Range
$0.017 - $0.019
52 Week Range
$0.017 - $0.044
Volume
510.12K
Avg Volume (10D)
357.82K
Market Cap
$5.41M
Price Chart
Market Statistics
Open$0.019
Previous Close$0.019
Day High$0.019
Day Low$0.017
52 Week High$0.044
52 Week Low$0.017
Valuation
Market Cap5.41M
Shares Outstanding284.88M
Price to Book1.44
Trading Activity
Volume510.12K
Value Traded9.25K
Bid$0.018 × 184,821
Ask$0.019 × 185,231
Performance
1 Day0.00%
5 Day-9.52%
13 Week-17.39%
52 Week-52.50%
YTD-9.52%
Technical Indicators
RSI (14)38.93
50-Day SMA$0.021
200-Day SMA$0.028
Latest News
Biotechnology
EVE Health Increases Capital Raising to $1.3m with $400,000 Cornerstone Investment
EVE Health Group lifts capital raise to $1.3m with $400k cornerstone, signalling reformulated-drug strategy and new science adviser amid Libbo launch.
1 min read
Biotechnology
EVE Health Group Raises $0.9m to Advance Reformulated Pharmaceutical Pipeline
EVE Health Group raises $0.904m via placement to push reformulated drug delivery pipeline, accelerating IP, regulatory work and licensing talks.
1 min read
Biotechnology
EVE Health Advances Reformulated Drugs Targeting Sexual Health and Cardiovascular Markets
EVE Health advances reformulated ED/PE sprays and Apixaban delivery, expanding its sexual health and cardiovascular pipeline.
2 min read
Biotechnology
EVE Health Group Launches Libbo ED Treatment and Men’s Health Platform
EVE Health (ASX: EVE) launches Libbo ED treatment and men’s health platform, unveiling an end-to-end digital pathway for nationwide access and scalable revenue.
1 min read